The first FDA-approved gene transfer therapy for patients with acute lymphoblastic leukemia will be available at a handful of approved hospitals, including OHSU Doernbecher.
Scientists have uncovered two related cytokines and associated genetic markers that may explain why some people develop progressive multiple sclerosis, or MS.
OHSU Hospital ranks 12th in the nation for “superior performance" in providing high-quality care, based on mortality, safety, efficiency, effectiveness, patient centeredness and equity, according to the 2017 Vizient Quality and Accountability Study.
OHSU experts recently imaged a Japanese suit of armor from the Portland Art Museum, helping to enhance curators' understanding about the armor's construction.